Control of Periodontal Infections

NCT01098448 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 187

Last updated 2010-04-02

No results posted yet for this study

Summary

The purpose of this study is to test combined effects of scaling and root planing with periodontal surgery, systemically administered amoxicillin and metronidazole, and/or local tetracycline on pocket depth reduction and attachment level "gain" in patients with chronic periodontitis.

Conditions

  • Periodontitis

Interventions

OTHER

scaling and root planing

scaling and root planing as a single therapy

DRUG

local tetracycline

local delivery of tetracycline fibers releasing approximately 1.7 mg/tooth in all pockets \>5mm

DRUG

systemic metronidazole and amoxicillin

systemic metronidazole (250 mg tid x 14) and amoxicillin (500 mg bid x 14

OTHER

surgery

periodontal surgery in residual pockets of \>4mm

DRUG

local antibiotics and systemic metronidazole and amoxicillin

1.7 mg/tooth tetracycline fiber plus metronidazole (250 mg tid x14d)and amoxicillin (500 mg bid x 14d)

OTHER

local tetracycline and periodontal surgery

local delivery of tetracycline fibers releasing approximately 1.7 mg/tooth in all pockets \>5mm and periodontal surgery in residual pockets of \>4mm

OTHER

periodontal surgery and systemic metronidazole and amoxicillin

surgery in residual pockets \>4mm and metronidazole (250mg tidx14d) and amoxicillin (500mg bidx14d)

OTHER

surgery, local tetracycline, systemic metronidazole and amoxicillin

periodontal surgery in residual pockets \>4mm, tetracycline ibers releasing approximately 1.7 mg/tooth in pockets \>5mm, systemic metronidazlo (250mg tidx14d) and amoxicillin (500 mg bidx14d)

Sponsors & Collaborators

  • Göteborg University

    collaborator OTHER
  • Boston University

    collaborator OTHER
  • The Forsyth Institute

    lead OTHER

Principal Investigators

  • J Max Goodson, DDS, PhD · The Forsyth Institute

  • Anne D Haffajee, BDS · The Forsyth Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-09-30
Primary Completion
2004-12-31
Completion
2004-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01098448 on ClinicalTrials.gov